Literature DB >> 27082145

Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer.

Ala-Eddin Al Moustafa1,2,3, Noor Al-Antary1, Tahar Aboulkassim4, Nizar Akil3,5,6, Gerald Batist2,4, Amber Yasmeen4.   

Abstract

ABSTRAT We recently performed 2 studies viewing the presence of Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human breast cancer in the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in breast cancer in Syrian women. Therefore, and based on our previous studies and present data, we reveal that 35 (32%) of 108 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high grade invasive ductal carcinomas (IDCs) with at least one positive lymph nodes, in comparison with EBV and high-risk HPVs-positive samples, which are low to intermediate grade IDCs, respectively. Future studies are needed to confirm the co-presence and the cooperation effect of these onco-viruses in human breast carcinogenesis and metastasis.

Entities:  

Keywords:  EBV; Syrian women; breast cancer; cancer phenotype; high-risk HPV

Mesh:

Year:  2016        PMID: 27082145      PMCID: PMC4964818          DOI: 10.1080/21645515.2016.1139255

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

1.  Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues.

Authors:  Ahmet Kalkan; Aykut Ozdarendeli; Yasemin Bulut; Hayrettin Yekeler; Bengu Cobanoglu; Mehmet Z Doymaz
Journal:  Med Princ Pract       Date:  2005 Jul-Aug       Impact factor: 1.927

2.  Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study.

Authors:  Tahar Aboulkassim; Amber Yasmeen; Nizar Akil; Gerald Batist; Ala-Eddin Al Moustafa
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.

Authors:  Ala-Eddin Al Moustafa
Journal:  Cell Adh Migr       Date:  2015-07-15       Impact factor: 3.405

Review 4.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

6.  Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.

Authors:  Lu Wang; Wen-Dong Tian; Xia Xu; Biao Nie; Juan Lu; Xiong Liu; Bao Zhang; Qi Dong; John B Sunwoo; Gang Li; Xiang-Ping Li
Journal:  Cancer       Date:  2013-11-04       Impact factor: 6.860

7.  Multiplex PCR/mass spectrometry screening of biological carcinogenic agents in human mammary tumors.

Authors:  Junping Peng; Ting Wang; Haijun Zhu; Junhua Guo; Ke Li; Qing Yao; Yonggang Lv; Juliang Zhang; Chenyang He; Jianghao Chen; Ling Wang; Qi Jin
Journal:  J Clin Virol       Date:  2014-07-23       Impact factor: 3.168

8.  Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Waleed S Mohamed; Fatma A El-Kassem; Saja J El-Khalidi; Mohamed M Hafez; Zeinab K Hassan
Journal:  J Egypt Natl Canc Inst       Date:  2012-07-10

9.  Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile.

Authors:  Francisco Aguayo; Noureen Khan; Chihaya Koriyama; Carolina González; Sandra Ampuero; Oslando Padilla; Luisa Solís; Yoshito Eizuru; Alejandro Corvalán; Suminori Akiba
Journal:  Infect Agent Cancer       Date:  2011-06-23       Impact factor: 2.965

10.  Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.

Authors:  Didier Riethmuller; Anne-Carole Jacquard; Jean Lacau St Guily; François Aubin; Xavier Carcopino; Pierre Pradat; André Dahlab; Jean-Luc Prétet
Journal:  BMC Public Health       Date:  2015-05-02       Impact factor: 3.295

View more
  24 in total

1.  Epstein-Barr virus and its association with Fascin expression in colorectal cancers in the Syrian population: A tissue microarray study.

Authors:  Noor Al-Antary; Hanan Farghaly; Tahar Aboulkassim; Amber Yasmeen; Nizar Akil; Ala-Eddin Al Moustafa
Journal:  Hum Vaccin Immunother       Date:  2017-03-28       Impact factor: 3.452

2.  Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients.

Authors:  Hamda Al-Thawadi; Ishita Gupta; Ayesha Jabeen; Faruk Skenderi; Tahar Aboulkassim; Amber Yasmeen; Mohammed I Malki; Gerald Batist; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Cancer Cell Int       Date:  2020-08-03       Impact factor: 5.722

3.  Co-Incidence of Epstein-Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women.

Authors:  Hamda Al-Thawadi; Lina Ghabreau; Tahar Aboulkassim; Amber Yasmeen; Semir Vranic; Gerald Batist; Ala-Eddin Al Moustafa
Journal:  Front Oncol       Date:  2018-07-02       Impact factor: 6.244

4.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

5.  Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples.

Authors:  Mohammed I Malki; Ishita Gupta; Queenie Fernandes; Tahar Aboulkassim; Amber Yasmeen; Semir Vranic; Ala-Eddin Al Moustafa; Hamda A Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

6.  Extracellular Vesicles in Epstein-Barr Virus Pathogenesis.

Authors:  Allaura S Cone; Sara B York; David G Meckes
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-03

7.  Incidence OF HPV and EBV in oral cancer and their clinico-pathological correlation- a pilot study of 108 cases.

Authors:  Shahi Vanshika; Agarwal Preeti; Qayoom Sumaira; Kumar Vijay; Tewari Shikha; Raghuvanshi Shivanjali; Singh Uma Shankar; Goel Madhu Mati
Journal:  J Oral Biol Craniofac Res       Date:  2021-01-23

8.  Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.

Authors:  Ishita Gupta; Gheyath K Nasrallah; Anju Sharma; Ayesha Jabeen; Maria K Smatti; Hamda A Al-Thawadi; Ali A Sultan; Moussa Alkhalaf; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Cancer Cell Int       Date:  2020-04-03       Impact factor: 5.722

9.  High-risk human papillomaviruses and Epstein-Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study.

Authors:  Karim Nagi; Ishita Gupta; Nawaf Jurdi; Ayesha Jabeen; Amber Yasmeen; Gerald Batist; Semir Vranic; Ala-Eddin Al-Moustafa
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

10.  Presence of HPV, EBV and HMTV Viruses Among Egyptian Breast Cancer Women: Molecular Detection and Clinical Relevance.

Authors:  Shimaa A Metwally; Maha A Abo-Shadi; Nasra F Abdel Fattah; Ahmed B Barakat; Omar A Rabee; Ahmed M Osman; Amany M Helal; Tarek Hashem; Manar M Moneer; Wassim Chehadeh; Samah A Loutfy
Journal:  Infect Drug Resist       Date:  2021-06-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.